The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 02-01-2024
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2025
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 07-05-2024
AUST R: 161298
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
AUST R: 18695
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
AUST R: 18770
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2026
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 30-10-2024
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2026
Availability: Unavailable
Updated: 31-10-2023
AUST R: 235933
Expected supply: 20 Dec 2024
Availability: Unavailable
Management action: Alternative generic products are available. Sponsor is working to expedite the next shipment. .
Updated: 25-11-2024
adrenaline (epinephrine) acid tartrate
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Expected supply: Unknown
Availability: Unavailable
Management action: Products are available in another presentation.
Updated: 14-08-2024
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 03-10-2024
AUST R: 81930
Expected supply: 31 Mar 2025
Availability: Unavailable
Updated: 03-12-2024
AUST R: 81931
Expected supply: 31 Mar 2025
Availability: Unavailable
Updated: 03-12-2024
METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe
AUST R: 75013
Expected supply: 15 Oct 2024
Availability: Available
Updated: 16-10-2024
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
AUST R: 316671
Expected supply: 26 Dec 2022
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 03-11-2022
HEPARIN SODIUM 5000IU/5mL (porcine mucous) injection ampoule
AUST R: 49232
Expected supply: 01 Jun 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 25-11-2024
AUST R: 144970
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Other brands are available.
Updated: 11-08-2023
PRIMAXIN imipenem 500mg and cilastatin 500mg (as sodium) powder for injection vial
AUST R: 10509
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An imipenem/cilastatin injection product may be available via the Special Access Scheme (SAS): https://www.tga.gov.au/products/prescribe-unapproved-therapeutic-good-health-practitioners
Updated: 30-04-2024
DBL Aciclovir 250mg/10mL Intravenous infusion injection vial
AUST R: 56809
Expected supply: 28 Feb 2025
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. Alternative generic products are available.
Updated: 03-12-2024
AMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
AUST R: 288798
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Alternative generic product is available.
Updated: 30-05-2024
AUST R: 94175
Expected supply: 31 Jan 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Clinect Pty Ltd, can be contacted for details on supply on 1800 899 005.
Updated: 01-08-2024
AUST R: 101243
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available and other strengths are available.
Updated: 27-09-2023
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 28-05-2024
AUST R: 61887
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other strengths are available
Updated: 02-02-2024
AUST R: 159338
Expected supply: 31 Jan 2025
Availability: Unavailable
Management action: Patients are advised to consult their healthcare professionals to discuss alternative treatment options
Updated: 03-12-2024
AUST R: 159342
Expected supply: 31 Jan 2025
Availability: Unavailable
Management action: Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
Updated: 03-12-2024
BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial
AUST R: 298672
Expected supply: 31 Oct 2024
Availability: Available
Updated: 07-11-2024
AUST R: 49822
Expected supply: 19 Sep 2024
Availability: Available
Updated: 19-09-2024
AUST R: 18845
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The sponsor is closely controlling the supply. The TGA is working to develop a management strategy.
Updated: 01-06-2024
ISOPRENALINE MACURE isoprenaline hydrochloride 1 mg/5 mL solution for injection ampoule
AUST R: 370377
Expected supply: 27 Jun 2025
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 28-06-2024
AUST R: 13455
Expected supply: 27 Sep 2024
Availability: Available
Updated: 02-10-2024
Pfizer (Australia) GENTAMICIN 80mg/2mL (as sulfate) injection BP ampoule
AUST R: 11376
Expected supply: 06 Jun 2025
Availability: Unavailable
Management action: An alternative generic product is available. An unregistered product has also been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 27-11-2024
dexamethasone sodium phosphate
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 8mg/2mL (as sodium) injection vial
AUST R: 178774
Expected supply: 21 Nov 2024
Availability: Available
Updated: 25-11-2024
AUST R: 313546
Expected supply: 15 Dec 2024
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 03-12-2024
AUST R: 60049
Expected supply: 31 Jan 2025
Availability: Unavailable
Management action: Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 10-09-2024
cefepime hydrochloride monohydrate
CEFEPIME KABI cefepime (as hydrochloride) 1 g powder for injection vial
AUST R: 227966
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative generic product is available.
Updated: 30-10-2024
cefepime hydrochloride monohydrate
CEFEPIME KABI cefepime (as hydrochloride) 2 g powder for injection vial
AUST R: 227965
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative generic product is available.
Updated: 30-10-2024
AUST R: 61885
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 09-05-2024
noradrenaline (norepinephrine) acid tartrate monohydrate
Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial
AUST R: 183622
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 16-09-2024
HEPARINISED SALINE 50IU/5mL (porcine mucous) injection ampoule
AUST R: 66684
Expected supply: 28 Feb 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 22-11-2024
DBL LEUCOVORIN CALCIUM folinic acid 300 mg/30 mL (as calcium folinate) injection vial
AUST R: 116688
Expected supply: 05 Sep 2024
Availability: Available
Updated: 05-09-2024
AUST R: 100517
Expected supply: 31 Jan 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 09-08-2024
JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial
AUST R: 352631
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: Sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.
Updated: 22-08-2024
AUST R: 15417
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Product will be replaced by METHOBLASTIN methotrexate (as sodium) 10 mg tablet blister pack ARTG 410933.
Updated: 18-06-2024
Updated: 08-11-2024
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
AUST R: 170446
Expected supply: 30 Jun 2025
Availability: Emergency Supply Only
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 04-10-2024
BOSENTAN RBX bosentan (as monohydrate) 62.5 mg film-coated tablet blister pack
AUST R: 257757
Expected supply: 09 Sep 2024
Availability: Available
Updated: 09-09-2024
AUST R: 337517
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available.
Updated: 12-07-2024
AUST R: 337512
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available.
Updated: 12-07-2024
benzathine benzylpenicillin tetrahydrate
AUST R: 147169
Expected supply: 31 Jan 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 03-12-2024
magnesium chloride hexahydrate
EXTRANEAL 7.5% w/v icodextrin peritoneal dialysis solution bag AHB5546
AUST R: 91344
Expected supply: 30 Jun 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
An unregistered product has been approved for supply under Section 19A. The approval holder, Vantive Pty Ltd, can be contacted for details on supply on 1800 920 133.
Updated: 02-08-2024
AUST R: 313549
Expected supply: 15 Dec 2024
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. Alternative brands are available.
Updated: 26-11-2024
adrenaline (epinephrine) acid tartrate
AUST R: 210672
Expected supply: 24 Jan 2025
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. Other dosage forms are available.
Updated: 09-10-2024
ASPEN ADRENALINE adrenaline (epinephrine) 1 mg/1 mL injection solution ampoule
AUST R: 131782
Expected supply: 16 Oct 2024
Availability: Available
Updated: 17-10-2024
PEGASYS peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe
AUST R: 91836
Expected supply: 01 Jun 2025
Availability: Available
Management action: The sponsor is closely controlling the supply. This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient
Updated: 01-10-2024
PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe
AUST R: 91837
Expected supply: 01 Jun 2025
Availability: Available
Management action: The sponsor is closely controlling the supply. This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient
Updated: 01-10-2024
AUST R: 158453
Expected supply: 31 Oct 2024
Availability: Available
Updated: 01-11-2024
NIVESTIM filgrastim (rbe) 120microgram/0.2mL injection solution pre-filled syringe
AUST R: 160106
Expected supply: 19 Sep 2024
Availability: Available
Updated: 20-09-2024
NIVESTIM filgrastim (rbe) 480microgram/0.5mL injection solution pre-filled syringe
AUST R: 160107
Expected supply: 19 Sep 2024
Availability: Available
Updated: 20-09-2024
EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe
AUST R: 375490
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe with safety lock system (ARTG 429090)
Updated: 23-08-2024
EXARANE FORTE enoxaparin sodium 120mg/0.8mL solution for injection prefilled syringe
AUST R: 375492
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE FORTE enoxaparin sodium 120mg/0.8mL solution for injection prefilled syringe with safety lock system (ARTG 429092)
Updated: 23-08-2024
magnesium chloride hexahydrate
DIANEAL Low Calcium with 2.5% w/v Glucose Peritoneal Dialysis Solution bag
AUST R: 16847
Expected supply: 31 Jul 2025
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 08-10-2024
magnesium chloride hexahydrate
DIANEAL Low Calcium with 1.5% w/v Glucose Peritoneal Dialysis Solution bag
AUST R: 16750
Expected supply: 31 Jul 2025
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 08-10-2024
NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule
AUST R: 219054
Expected supply: 17 Feb 2025
Availability: Available
Management action: An unregistered product has been approved for supply under Section 19A. Please contact Juno Pharmaceuticals on: 03 88881288 for further details.
Updated: 11-10-2024
ACETYLCYSTEINE-LINK INJECTION acetylcysteine 2g/10mL concentrated injection ampoule
AUST R: 170803
Expected supply: 27 Jan 2025
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment.
If Australian registered stock is unavailable, stock may be available via the Special Access Scheme (SAS).
Updated: 02-12-2024
AUST R: 14328
Expected supply: 31 Jan 2025
Availability: Unavailable
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. The approval holder, Global Medical Solutions, can be contacted for details on supply on 02 9503 8100.
Updated: 28-11-2024
HEPARIN SODIUM 25000IU/5mL (porcine mucous) injection ampoule
AUST R: 49236
Expected supply: 31 Jan 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 26-11-2024
AUST R: 46942
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 13-09-2024
ASPEN ADRENALINE INJECTION adrenaline (epinephrine) 1 mg/10 mL solution for injection ampoule
AUST R: 162463
Expected supply: 15 Oct 2024
Availability: Available
Updated: 16-10-2024
EMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial
AUST R: 346216
Expected supply: 07 Oct 2024
Availability: Available
Updated: 15-10-2024
noradrenaline (norepinephrine) acid tartrate monohydrate
AUST R: 232700
Expected supply: 03 Dec 2024
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment.
Updated: 20-11-2024
adrenaline (epinephrine) acid tartrate
AUST R: 282377
Expected supply: 03 Dec 2024
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. Other dosage forms are available.
Updated: 20-11-2024
DBL ACETYLCYSTEINE injection concentrate acetylcysteine 2 g/ 10 mL injection ampoule
AUST R: 121503
Expected supply: 31 Mar 2025
Availability: Limited Availability
Management action: Pfizer has a limited amount of stock available for direct shipping. Please contact Pfizer on 1800 675 229 for details on how to order. Sponsor is working to expedite the next shipment.
Updated: 04-12-2024
Digoxinspecific antibody fragment F(ab) (Ovine)
DigiFab Digoxin-specific antibody fragment f(Ab) (ovine) 40mg powder for injection vial
AUST R: 203623
Expected supply: 28 Oct 2024
Availability: Available
Updated: 29-10-2024
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 12048
Expected supply: 14 Mar 2025
Availability: Available
Management action: The sponsor is working to expedite the next shipment.
Updated: 07-11-2024
Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial
AUST R: 12723
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The product will be replaced by: PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial ARTG 399600
Updated: 15-10-2024
EXARANE enoxaparin sodium 20mg/0.2mL solution for injection prefilled syringe
AUST R: 375494
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE enoxaparin sodium 20mg/0.2mL solution for injection prefilled syringe with safety lock system (ARTG 429094)
Updated: 16-10-2024
DBL HEPARIN SODIUM 5000IU/1mL (porcine mucous) injection BP ampoule
AUST R: 12881
Expected supply: 11 Apr 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 13-11-2024
Updated: 01-11-2024
AUST R: 364527
Expected supply: 29 Nov 2024
Availability: Available
Updated: 03-12-2024
noradrenaline (norepinephrine) acid tartrate monohydrate
AUST R: 248512
Expected supply: 06 Dec 2024
Availability: Limited Availability
Management action: The sponsor is working to expedite next shipment
Updated: 19-11-2024
phenoxymethylpenicillin potassium
ASPECILLIN VK phenoxymethylpenicillin 250mg (as potassium) tablet bottle
AUST R: 200136
Expected supply: 31 Jan 2025
Availability: Limited Availability
Management action: Alternative generic products are available.
Updated: 28-11-2024
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/